Define Dengue Fever. Describe its classification, clinical features, investigations and management.
Definition
- Dengue is an acute arboviral infection caused by the dengue virus (a flavivirus, 4 serotypes den 1–4), transmitted by the Aedes aegypti mosquito.
- A second infection with a different serotype increases the risk of severe disease (antibody-dependent enhancement).
Phases of Illness
Febrile phase (2–7 days) → Critical phase (around defervescence, days 3–7) — plasma leakage → Recovery phase — reabsorption of fluid
WHO Classification (2009)
| Category | Features |
|---|---|
| Dengue without warning signs | Fever + 2 of: nausea/vomiting, rash, aches, leucopenia, positive tourniquet test |
| Dengue with warning signs | Abdominal pain, persistent vomiting, mucosal bleeding, lethargy, liver > 2 cm, rising haematocrit with rapid fall in platelets, clinical fluid accumulation |
| Severe dengue | Severe plasma leakage (shock/DSS, fluid accumulation with respiratory distress), severe bleeding, or organ impairment |
Clinical Features
- High fever with severe headache, retro-orbital pain, myalgia and arthralgia ('breakbone fever'), and rash.
- Positive tourniquet test, thrombocytopenia and leucopenia.
- Plasma leakage (pleural effusion, ascites, rising haematocrit) in the critical phase → hypovolaemic shock (dengue shock syndrome).
Investigations
- NS1 antigen (positive early, days 1–5); IgM/IgG serology (after day 5).
- CBC — thrombocytopenia, leucopenia, and a rising haematocrit (a key marker of plasma leakage).
- Serial monitoring of haematocrit, platelets and warning signs.
Management
- No specific antiviral — treatment is supportive, centred on careful fluid management.
- Isotonic crystalloid for those with warning signs/leakage, titrated to the haematocrit and vital signs (avoid both under- and over-hydration).
- Paracetamol for fever; avoid aspirin and NSAIDs (bleeding risk).
- Platelet transfusion only for significant bleeding — not for a low count alone.
- Manage dengue shock syndrome with prompt fluid resuscitation.
Older (DHF/DSS) Grading
| Grade | Features |
|---|---|
| DF | Fever + non-specific symptoms |
| DHF I | Above + thrombocytopenia/haemoconcentration + positive tourniquet test |
| DHF II | Grade I + spontaneous bleeding |
| DHF III (DSS) | Circulatory failure (narrow pulse pressure, hypotension) |
| DHF IV (DSS) | Profound shock (undetectable BP/pulse) |
Pathophysiology of Severe Dengue
Immune activation increases vascular permeability, causing plasma leakage (into pleural/peritoneal spaces), haemoconcentration and hypovolaemic shock; thrombocytopenia and coagulopathy contribute to bleeding — hence the emphasis on monitoring haematocrit and careful fluid therapy.
Criteria for Discharge
- Afebrile > 24–48 h without antipyretics, improving clinically and appetite returning.
- Rising platelet trend, stable haematocrit, and no respiratory distress from effusions/ascites.
Tourniquet Test
A blood-pressure cuff is inflated midway between systolic and diastolic for ~5 minutes; > 10–20 petechiae per square inch is positive, indicating capillary fragility — a simple bedside clue in dengue.
Warning Signs to Watch
- Severe abdominal pain, persistent vomiting, mucosal bleeding, lethargy/restlessness.
- Tender enlarging liver, and a rising haematocrit with a rapid drop in platelets — trigger closer monitoring/admission.
Prognosis
With timely recognition of the critical phase and careful fluid management, most children recover fully; deaths occur mainly from unrecognised plasma leakage/shock or severe bleeding — both largely preventable with monitoring.
Prevention
- Vector control — eliminate Aedes breeding sites (stored water), larvicides, personal protection.
- Community awareness; dengue vaccine only in seropositive individuals (per current guidance).
All questions in Infectious Diseases
- Q1Define Childhood Tuberculosis. Describe its pathogenesis, types, clinical features and treatment. ★
- Q2Define Enteric Fever. Describe its pathogenesis, clinical features, investigations and management. ★
- Q3Define Malaria. Describe its clinical features, investigations, management and prognosis. ★
- Q4Define Dengue Fever. Describe its classification, clinical features, investigations and management. ★
- Q5Define Measles. Describe its clinical features, investigations, management and stages. ★
- SN1Define HIV Infection in Children. Describe its clinical features, diagnosis and management. ★
- SN2Describe the including Neonatal Tetanus of Tetanus. ★
- SN3Define Chickenpox. Describe its clinical features, complications and management.
- SN4Define Mumps. Describe its clinical features, complications, management and prevention.
- SN5Define Rubella & Congenital Rubella Syndrome. Describe its prevention and diagnosis.
- SN6Define Diphtheria. Describe its clinical features, complications, management and types.
- SN7Describe the visceral Leishmaniasis of Kala-azar.